| Literature DB >> 34395595 |
Nahed Gomaa Kasem1, Maha Al-Ashmawy1, Mohammed Elsherbini1, Adel Abdelkhalek1.
Abstract
OBJECTIVE: This work investigated the antimicrobial resistance (AMR) and virulence of Escherichia coli and Staphylococcus aureus in communally consumed cheeses in Egypt.Entities:
Keywords: Antimicrobial resistance; E. coli; MAR index; PCR; S. aureus
Year: 2021 PMID: 34395595 PMCID: PMC8280994 DOI: 10.5455/javar.2021.h509
Source DB: PubMed Journal: J Adv Vet Anim Res ISSN: 2311-7710
Primers utilized to identify E. coli genes.
| Gene | Primer (5′→3′) | Size | References |
|---|---|---|---|
| 5′-ATAAATCGCCATTCGTTGACTAC-3′ | 180 bp | [ | |
| 5′-AGAACGCCCACTGAGATCATC-3′ | |||
| 5′-GGCACTGTCTGAAACTGCTCC-3′ | 255 bp | ||
| 5′-TCGCCAGTTATCTGACATTCTG-3′ | |||
| 5′-GACCCGGCACAAGCATAAGC-3′ | 384 bp | ||
| 5′-CCACCTGCAGCAACAAGAGG-3′ |
Primers utilized to identify S. aureus gene.
| Primer (5’→3’) | Size | References | |
|---|---|---|---|
| 5’-GCGATTGATGGTGATACGGTT-3’ | 270 bp | [ | |
| 5’-AGCCAAGCCTTGACGAACTAAAGC-3’ |
Antibiotic disks, concentrations, and action on pathogens.
| Antibiotic | Sensitivity disc content (ug) | Resistant (mm) | Intermediate (mm) | Susceptible (mm) |
|---|---|---|---|---|
| 30 | ≤12 | 13–15 | ≥16 | |
| 10 IU | ≤20 | 21–28 | ≥29 | |
| 10 | ≤12 | 13–14 | ≥15 | |
| 30 | ≤14 | 15–18 | ≥19 | |
| 30 | ≤13 | 14–17 | ≥18 | |
| 15 | ≤15 | 16–21 | ≥22 | |
| 30 | ≤13 | 14–18 | ≥19 | |
| 5 | ≤15 | 15–19 | ≥20 | |
| 30 | ≤14 | 15–18 | ≥19 | |
| 15 | ≤13 | 14–22 | ≥23 | |
| 30 | ≤17 | 18–22 | ≥23 | |
| 10 | ≤13 | 14–17 | ≥18 | |
| 30 | ≤14 | 15–17 | ≥18 | |
| 25 | ≤10 | 11–15 | ≥16 |
Incidence of Enterobacteriaceae and E. coli in cheese samples.
| Cheese type | Total samples | Positive samples (%) | Total isolates | Enterobacter (%) | Shigella (%) | Yerisinia (%) | Klebsiella (%) | Proteus (%) | |
|---|---|---|---|---|---|---|---|---|---|
| 25 | 12 (48%) | 30 | 26 (86.6%) | 2 (6.6 %) | 1 (3.3%) | 1 (3.3%) | – | – | |
| 25 | 8 (32%) | 14 | 12 (85.7%) | 2 (14.2 %) | – | – | – | – | |
| 25 | 9 (36%) | 23 | 12 (52.1%) | 10 (43.4%) | 1 (4.3%) | – | – | – | |
| 25 | 18 (72%) | 54 | 21 (38.8%) | 26 (48.1%) | 3 (5.5%) | – | 2 (3.7%) | 2 (3.7%) |
Incidence of S. aureus in cheese samples.
| Cheese type | Total samples | Positive samples (%) |
|---|---|---|
| 25 | 15 (60%) | |
| 25 | 12 (48%) | |
| 25 | 12 (48%) | |
| 25 | 18 (72%) |
Serological characterization of E. coli isolates (n = 17).
| Strain | No. (%) of isolates | Identified serotypes |
|---|---|---|
| 7 (41%) | O146:H21, O17:H18, O119:H6, O119:H6, O146:H21, O119:H6, O114:H4 | |
| 5 (29%) | O121:H7, O26:H11, O103:H2, O111:H2, O26:H11 | |
| 4 (24%) | O128:H2 | |
| 1 (6%) | O159 |
Occurrence of virulence genes of E. coli isolates (n = 17) in cheese samples.
| Serotype | No. (%) of isolates | Stx1 | Stx2 | Intimin gene ( | |||
|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | ||
| 1 (5.8%) | 0 | 0 | 1 | 100 | 0 | 0 | |
| 2 (11.76%) | 2 | 100 | 2 | 100 | 2 | 100 | |
| 1 (5.8%) | 1 | 100 | 1 | 100 | 0 | 0 | |
| 1 (5.8%) | 1 | 100 | 1 | 100 | 1 | 100 | |
| 1 (5.8%) | 1 | 100 | 0 | 0 | 0 | 0 | |
| 3 (17.6%) | 3 | 100 | 2 | 66.7 | 0 | 0 | |
| 1 (5.8%) | 0 | 0 | 1 | 100 | 0 | 0 | |
| 4 (23.5%) | 4 | 100 | 0 | 0 | 0 | 0 | |
| 2 (11.7%) | 0 | 0 | 2 | 100 | 0 | 0 | |
| 1 (5.8%) | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17 | 12 | 70.58% | 10 | 58.82% | 3 | 17.6% | |
Figure 1.Multiplex PCR for stx1 (180 bp), stx2 (255 bp), and eaeA (384 bp) to identify E. coli. Lane-M: 100 bp DNA ladder; Lane-C+: positive control; Lane-C−: negative control; Lanes 2, 3 (O26), and 5 (O111): positive E. coli for stx1, stx2, and eaeA genes; Lanes 4 (O103), 7, and 8 (O119): positive E. coli for stx1 and stx2 genes; Lanes 6 (O114), 9 (O119), 11, 12, 13, and 14 (O128): positive E. coli for stx1; Lanes 1 (O17), 10 (O121), 15, and 16 (O146): positive strain for stx2; and Lane 17 (O159): negative E. coli for stx1, stx2, and eaeA.
Figure 2.PCR of nuc (270 bp) aimed at S. aureus identification. Lane-M: 100 bp DNA ladder. Lane-1: positive control; Lane-2: negative control; Lanes 1–10: positive for nuc gene.
Figure 3.Antibiotic susceptibility of isolated E. coli.
Antibiotic resistance of E. coli isolates.
| No. | Strain | Antibiotic resistance | MAR index |
|---|---|---|---|
| O128: H2 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin, Ampicillin, Tetracycline, Ciprofloxacin, Doxycycline, Gentamicin | 1 | |
| O128: H2 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin, Ampicillin | 0.714 | |
| O128: H2 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin | 0.428 | |
| O128: H2 | Erythromycin, Nalidixic acid, Cefotaxime | 0.214 | |
| O119: H6 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin, Ampicillin, Tetracycline, Ciprofloxacin, Doxycycline | 0.928 | |
| O119: H6 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole | 0.500 | |
| O119: H6 | Erythromycin, Nalidixic acid | 0.134 | |
| O26: H11 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin, Ampicillin, Tetracycline, Ciprofloxacin | 0.857 | |
| O26 : H11 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin | 0.357 | |
| O146: H21 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin, Ampicillin, Tetracycline, Ciprofloxacin | 0.857 | |
| O146: H21 | Erythromycin, Nalidixic acid, Cefotaxime | 0.214 | |
| O111: H2 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole, Amikacin, Kanamycin | 0.643 | |
| O17: H18 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin, Penicillin, Sulphamethoxazole | 0.500 | |
| O103: H2 | Erythromycin, Nalidixic acid, Cefotaxime, Vancomycin, Cephalothin | 0.357 | |
| O159 | Erythromycin, Nalidixic acid, Cefotaxime | 0.214 | |
| O121: H7 | Erythromycin, Nalidixic acid | 0.143 | |
| O114: H4 | Erythromycin | 0.071 | |
| Average = 0.478 | |||
Distribution of MDR of E. coli isolates (n = 17).
| Item | Number | % |
|---|---|---|
| 14 | 82.4 | |
| 3 | 17.6 |
Figure 4.Antibiotic susceptibility of isolated S. aureus.
Antibiotic resistance of S. aureus isolates (n = 10).
| No. | Strain | Antibiotic resistance | MAR index |
|---|---|---|---|
| Kanamycin, Cephalothin, Erythromycin, Tetracycline, Cefotaxime, Gentamicin, Ciprofloxacin, Ampicillin, Amikacin, Vancomycin.Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole | 1 | ||
| Kanamycin, Cephalothin, Erythromycin, Tetracycline, Cefotaxime, Gentamicin, Ciprofloxacin, Ampicillin, Amikacin.Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole | 0.928 | ||
| Kanamycin, Cephalothin, Erythromycin, Tetracycline, Cefotaxime, Gentamicin, Ciprofloxacin, Ampicillin Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole | 0.857 | ||
| Kanamycin, Cephalothin, Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole, Erythromycin, Tetracycline, Cefotaxime, Gentamicin. | 0.714 | ||
| Kanamycin, Cephalothin, Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole, Erythromycin. | 0.500 | ||
| Kanamycin, Cephalothin, Penicillin, Doxycycline, Nalidixic acid, Sulphamethoxazole | 0.428 | ||
| Kanamycin, Cephalothin, Penicillin, Doxycycline. | 0.286 | ||
| Kanamycin, Cephalothin, Penicillin. | 0.214 | ||
| Kanamycin, Cephalothin, Penicillin. | 0.214 | ||
| Kanamycin, Cephalothin. | 0.143 | ||
| Average = 0.529 | |||
MDR of S. aureus isolates (n = 10).
| Item | Number | % |
|---|---|---|
| 9 | 90 | |
| 1 | 10 |